Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients

Pain

Volumn 153, Issue 2, 2012, Pages 311-318

  Neziri, Alban Y ^a   Dickenmann, Martina ^a   Scaramozzino, Pasquale ^b,c   Andersen, Ole K ^d   Arendt Nielsen, Lars ^d   Dickenson, Anthony H ^e   Curatolo, Michele ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d AALBORG UNIVERSITY   (Denmark)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 Hydroxytryptamine 3 receptor antagonist; Central sensitization; Chronic low back pain; Conditioned pain modulation; Experimental pain; Tropisetron

Indexed keywords

SODIUM CHLORIDE; TROPISETRON;

ADULT; ARTICLE; CHRONIC LOW BACK PAIN; CONTROLLED STUDY; ELECTROSTIMULATION; EXPLORATORY RESEARCH; FEMALE; HUMAN; HYPERSENSITIVITY; HYPOTHESIS; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NEUROMODULATION; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; PRESSURE; PRIORITY JOURNAL; REFLEX; SINGLE DRUG DOSE; VISUAL ANALOG SCALE;

ADULT; AGED; CHRONIC PAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERALGESIA; INDOLES; LOW BACK PAIN; MALE; MIDDLE AGED; PLACEBOS; REACTION TIME; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855913347     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2011.10.008     Document Type: Article

References (45)

1. L. Arendt-Nielsen, J. Brennum, S. Sindrup, and P. Bak Electrophysiological and psychophysical quantification of central temporal summation of the human nociceptive system Eur J Appl Physiol 68 1994 266 273 (Pubitemid 24106442)
2. P. Bajaj, T. Graven-Nielsen, and L. Arendt-Nielsen Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study Pain 93 2001 107 114 (Pubitemid 32568395)
3. B.H. Baltagi Econometric analysis of panel data 4th ed. 2008 Wiley New York
4. O. Bandschapp, J. Filitz, A. Urwyler, W. Koppert, and W. Ruppen Tropisetron blocks analgesic action of acetaminophen: a human pain model study Pain 152 2011 1304 1310
5. B. Banic, S. Petersen-Felix, O.K. Andersen, B.P. Radanov, P.M. Villiger, L. Arendt-Nielsen, and M. Curatolo Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia Pain 107 2004 7 15 (Pubitemid 38058693)
6. K. Bannister, L.A. Bee, and A.H. Dickenson Preclinical and early clinical investigations related to monoaminergic pain modulation Neurotherapeutics 6 2009 703 712
7. A. Beck, R. Steer, and G. Brown Beck depression inventory 1996 The Psychological Corporation San Antonio, TX
8. K. Blumenstiel, A. Gerhardt, R. Rolke, C. Bieber, J. Tesarz, H.C. Friederich, W. Eich, and R.D. Treede Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia Clin J Pain 27 2011 682 690
9. N. Bogduk On the definitions and physiology of back pain, referred pain, and radicular pain Pain 147 2009 17 19
10. M. Curatolo, S. Petersen-Felix, L. Arendt-Nielsen, C. Giani, A.M. Zbinden, and B.P. Radanov Central hypersensitivity in chronic pain after whiplash injury Clin J Pain 17 2001 306 315 (Pubitemid 33152002)
11. J.A. Desmeules, C. Cedraschi, E. Rapiti, E. Baumgartner, A. Finckh, P. Cohen, P. Dayer, and T.L. Vischer Neurophysiologic evidence for a central sensitization in patients with fibromyalgia Arthritis Rheum 48 2003 1420 1429 (Pubitemid 36554542)
12. L. Farber, T. Stratz, W. Bruckle, M. Spath, D. Pongratz, J. Lautenschlager, I. Kotter, B. Zoller, H.H. Peter, G. Neeck, R. Alten, and W. Muller Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group Scand J Rheumatol Suppl 113 2000 49 54
13. L. Farber, T.H. Stratz, W. Bruckle, M. Spath, D. Pongratz, J. Lautenschlager, I. Kotter, B. Zoller, H.H. Peter, G. Neeck, D. Welzel, and W. Muller Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients Int J Clin Pharmacol Res 21 2001 1 13 (Pubitemid 33009868)
14. R. Freynhagen, R. Baron, U. Gockel, and T.R. Tolle PainDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain Curr Med Res Opin 22 2006 1911 1920 (Pubitemid 44663395)
15. U. Haus, B. Varga, T. Stratz, M. Spath, and W. Muller Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain Scand J Rheumatol Suppl 113 2000 55 58 (Pubitemid 32016438)
16. K. Hocherl, L. Farber, S. Ladenburger, D. Vosshage, T. Stratz, W. Muller, and H. Grobecker Effect of tropisetron on circulating catecholamines and other putative biochemical markers in serum of patients with fibromyalgia Scand J Rheumatol Suppl 113 2000 46 48 (Pubitemid 32016436)
17. P. Hrycaj, T. Stratz, P. Mennet, and W. Muller Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome - a preliminary study J Rheumatol 23 1996 1418 1423 (Pubitemid 26258766)
18. M. Koelbaek Johansen, T. Graven-Nielsen, A. Schou Olesen, and L. Arendt-Nielsen Generalised muscular hyperalgesia in chronic whiplash syndrome Pain 83 1999 229 234 (Pubitemid 29479281)
19. C. Koeppe, C. Schneider, K. Thieme, S. Mense, T. Stratz, W. Muller, and H. Flor The influence of the 5-HT3 receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study Scand J Rheumatol Suppl 119 2004 24 27 (Pubitemid 39180182)
20. R. Kohnen, L. Farber, and M. Spath The assessment of vegetative and functional symptoms in fibromyalgia patients: the tropisetron experience Scand J Rheumatol Suppl 119 2004 67 71 (Pubitemid 39180193)
21. L. Laux, P. Glanzmann, P. Schaffner, and C.D. Spielberger State-Trait-Angstinventar (STAI) 1981 Hogrefe Verlag Göttingen, Germany
22. G.J. McCleane, R. Suzuki, and A.H. Dickenson Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study Anesth Analg 97 2003 1474 1478 (Pubitemid 37310150)
23. M. Moog, J. Quintner, T. Hall, and M. Zusman The late whiplash syndrome: a psychophysical study Eur J Pain 6 2002 283 294 (Pubitemid 35177565)
24. W. Muller, and T. Stratz Results of the intravenous administration of tropisetron in fibromyalgia patients Scand J Rheumatol Suppl 113 2000 59 62 (Pubitemid 32016439)
25. A.Y. Neziri, M. Curatolo, A. Bergadano, S. Petersen-Felix, A. Dickenson, L. Arendt-Nielsen, and O.K. Andersen New method for quantification and statistical analysis of nociceptive reflex receptive fields in humans J Neurosci Methods 178 2009 24 30
26. A.Y. Neziri, M. Curatolo, E. Nuesch, P. Scaramozzino, O.K. Andersen, L. Arendt-Nielsen, and P. Juni Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessment Pain 152 2011 1146 1155
27. A.Y. Neziri, S. Haesler, S. Petersen-Felix, M. Muller, L. Arendt-Nielsen, J.B. Manresa, O.K. Andersen, and M. Curatolo Generalized expansion of nociceptive reflex receptive fields in chronic pain patients Pain 151 2010 798 805
28. S. Perrot, A.H. Dickenson, and R.M. Bennett Fibromyalgia: harmonizing science with clinical practice considerations Pain Pract 8 2008 177 189 (Pubitemid 351663360)
29. K. Riering, C. Rewerts, and W. Zieglgansberger Analgesic effects of 5-HT3 receptor antagonists Scand J Rheumatol Suppl 119 2004 19 23 (Pubitemid 39180181)
30. M. Roland, and R. Morris A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain Spine (Phila Pa 1976) 8 1983 141 144 (Pubitemid 13089565)
31. A.K. Rosenstiel, and F.J. Keefe The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment Pain 17 1983 33 44 (Pubitemid 13004472)
32. E. Sarlani, and J.D. Greenspan Evidence for generalized hyperalgesia in temporomandibular disorders patients Pain 102 2003 221 226 (Pubitemid 36369299)
33. R.B. Sheather Reid, and M.L. Cohen Psychophysical evidence for a neuropathic component of chronic neck pain Pain 75 1998 341 347 (Pubitemid 28160145)
34. J. Sorensen, T. Graven-Nielsen, K.G. Henriksson, M. Bengtsson, and L. Arendt-Nielsen Hyperexcitability in fibromyalgia J Rheumatol 25 1998 152 155 (Pubitemid 28060135)
35. M. Spath, T. Stratz, L. Farber, U. Haus, and D. Pongratz Treatment of fibromyalgia with tropisetron - dose and efficacy correlations Scand J Rheumatol Suppl 119 2004 63 66 (Pubitemid 39180192)
36. M. Spath, T. Stratz, G. Neeck, I. Kotter, B. Hammel, C.C. Amberger, U. Haus, L. Farber, D. Pongratz, and W. Muller Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia Scand J Rheumatol 33 2004 267 270 (Pubitemid 39180172)
37. T. Stratz, L. Farber, B. Varga, C. Baumgartner, U. Haus, and W. Muller Fibromyalgia treatment with intravenous tropisetron administration Drugs Exp Clin Res 27 2001 113 118 (Pubitemid 32601080)
38. T. Stratz, and W. Muller Treatment of chronic low back pain with tropisetron Scand J Rheumatol Suppl 119 2004 76 78 (Pubitemid 39180195)
39. R. Suzuki, S. Morcuende, M. Webber, S.P. Hunt, and A.H. Dickenson Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways Nat Neurosci 5 2002 1319 1326 (Pubitemid 35417767)
40. J. Tolk, R. Kohnen, and W. Muller Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice Scand J Rheumatol Suppl 119 2004 72 75 (Pubitemid 39180194)
41. P. Vergne-Salle, C. Dufauret-Lombard, C. Bonnet, A. Simon, R. Treves, H. Bonnabau, and P. Bertin A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia Eur J Pain 15 2011 509 514
42. J.E. Ware, K.K. Snow, M. Kosinski, and B. Gandek SF-36 Health Survey: manual and interpretation guide 1993 New England Medical Center, The Health Institute Boston, MA
43. H. Wolf Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists Scand J Rheumatol Suppl 113 2000 37 45 (Pubitemid 32016435)
44. C.J. Woolf, and M.W. Salter Neuronal plasticity: increasing the gain in pain Science 288 2000 1765 1769
45. D. Yarnitsky, L. Arendt-Nielsen, D. Bouhassira, R.R. Edwards, R.B. Fillingim, M. Granot, P. Hansson, S. Lautenbacher, S. Marchand, and O. Wilder-Smith Recommendations on terminology and practice of psychophysical DNIC testing Eur J Pain 14 2010 339